Md. Boggild et al., MOLECULAR-GENETIC STUDIES OF SPORADIC PITUITARY-TUMORS, The Journal of clinical endocrinology and metabolism, 78(2), 1994, pp. 387-392
Tumor formation may result from the activation of dominant oncogenes o
r by inactivation of recessive, tumor suppressor genes. The role of su
ch mutations in the development of pituitary tumors has been studied.
Tumors from 88 patients, representing the 4 major classes of adenoma,
were investigated. In DNA extracted from matched leukocyte and tumor s
amples, allelic deletions were sought with 15 probes identifying restr
iction fragment length polymorphisms on chromosomes 1, 5, 10, 11, 13,
17, 20, and 22. Evidence of amplification or rearrangement of 10 recog
nized cellular oncogenes (N-ras, mycL1, mycN, myc, H-ros, bcl1, H-stf1
, sea, kraS2, and fos) was sought in tumor DNA. Activating dominant mu
tations of G(s alpha) were detected using the polymerase chain reactio
n to amplify exons 7-10 and hybridizing the product to normal and muta
nt allele-specific oligonucleotides. Allelic deletions on chromosome 1
1 were identified in 16 tumors (18%) representing all 4 major subtypes
. Deletions on other autosomes were observed in less than 6% of tumors
. Three adenomas had deletions on multiple autosomes, 2 of these were
aggressive and recurrent. Mutations of G(s alpha) were confirmed to be
specific to somatotrophinomas, being identified in 36% of such tumors
in this series. No evidence of amplification or rearrangement of othe
r recognized cellular oncogenes was found. Inactivation of a recessive
oncogene on chromosome 11 is an important and possibly early event in
the development of the four major types of pituitary adenoma, whereas
activating mutations of G(s alpha) are confirmed to be specific to so
matotropinomas. Two aggressive tumors were found to have multiple auto
somal losses, suggesting a multistep progression in the development of
tumors of this phenotype.